HBR REALTY (HBRE3) Main Indicators
Basic Data - HBRE3
| Company | HBR REALTY |
| Corporate Name | HBR REALTY EMPREENDIMENTOS IMOBILIARIOS S/A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Deter patrimônio constituído por bens imóveis e direitos a eles relativos; administrar bens imóveis próprios e de terceiros; e participar. como sócia ou acionista. em outras sociedades. |
| Share | HBRE3 |
| Quote Date | 11/08/2024 |
| Share Type | ON |
| Last Closing | R$ 4.41 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 4.95 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Financeiro |
| Subsector | Exploração de Imóveis |
| Segment | Exploração de Imóveis |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 11/09/2024 | |
Relative Prices - HBRE3
| Price/Earnings | 4.62 |
| Price/SBV | 0.23 |
| Price/Net Sales | 2.88 |
| Price/CFO | -1.35 |
| Price/FCF | -1.23 |
| Price/Total Assets | 0.09 |
| Price/EBIT | 1.10 |
| Price/Working Capital | 2.81 |
| Price/NCAV | -0.17 |
| EV/EBIT | 4.53 |
| EV/EBITDA | 4.49 |
| EV/Net Sales | 11.91 |
| EV/CFO | -5.60 |
| EV/FCF | -5.10 |
| EV/Total Assets | 0.39 |
| Company Market Cap | R$ 455.06 M |
| Enterprise Value | R$ 1.88 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 4.41 |
| Share Price Date | 11/08/2024 |
| Dividend Yield | 0.00% |
| Updated 11/09/2024 | |
Income Statement - HBRE3
| Net Revenue | R$ 158.04 M |
| Gross Result | R$ 126.52 M |
| EBIT | R$ 415.46 M |
| Depreciation and Amortization | - R$ 3.82 M |
| EBITDA | R$ 419.28 M |
| Net Profit | R$ 98.47 M |
| Net Profit/Share | R$ 0.95 |
| Updated 11/07/2024 | |
| Net Revenue | R$ 41.54 M |
| Gross Result | R$ 33.41 M |
| EBIT | R$ 21.52 M |
| Depreciation and Amortization | - R$ 1.19 M |
| EBITDA | R$ 22.71 M |
| Net Profit | - R$ 17.26 M |
| Profit/Share | - R$ 0.17 |
| Updated 11/07/2024 | |
Price and Volume Behavior - HBRE3
| Lowest Price 52 weeks | R$ 4.38 |
| Highest Price 52 weeks | R$ 6.87 |
| Variation 2024 | -22.36% |
| Variation 1 year | -10.00% |
| Variation 2 years(total) | -31.31% |
| Variation 2 years(yearly) | -17.10% |
| Variation 3 years(total) | -62.15% |
| Variation 3 years(yearly) | -27.64% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 2.04 M |
| Updated 11/09/2024 | |
Returns and Margins - HBRE3
| Return on Initial Tangible Capital | 6.72% |
| Return on Initial Invested Capital | 9.04% |
| Pre-Tax Return on Initial Tangible Capital | 10.18% |
| Pre-Tax Return on Initial Invested Capital | 13.70% |
| Return on Initial Shareholder´s Equity | 5.16% |
| Return on Initial Asset | 2.29% |
| Gross Margin | 80.06% |
| Net Margin | 62.31% |
| EBIT Margin | 262.88% |
| EBITDA Margin | 265.30% |
| Initial Asset Turnover | 0.04 |
| Financial Leverage | 2.42 |
| Liabilities/Net Worth | 1.42 |
| Net Debt/EBITDA | 3.40 |
| Updated 11/07/2024 | |
Balance Sheet - HBRE3
| Cash and Cash Equivalents | R$ 24.23 M |
| Total Assets | R$ 4.83 B |
| Short-Term Debt | R$ 127.18 M |
| Long-Term Debt | R$ 1.32 B |
| Gross Debt | R$ 1.45 B |
| Net Debt | R$ 1.43 B |
| Shareholder´s Equity | R$ 1.99 B |
| Share Book Value | R$ 19.31 |
| Common Shares | 103,188,981 |
| Preferred Shares | 0 |
| Total | 103,188,981 |
| Common Shares in Treasury | 287,649 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 287,649 |
| Common Shares (Except Treasury) | 102,901,332 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 102,901,332 |
| Updated 11/07/2024 | |
Cash Flow - HBRE3
| Operating Cash Flow | - R$ 336.24 M |
| Cash Flow from Investments | R$ 88.48 M |
| Financing Cash Flow | R$ 228.73 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 19.03 M |
| Updated 11/07/2024 | |
| Operating Cash Flow | - R$ 18.09 M |
| Cash Flow from Investments | R$ 13.59 M |
| Financing Cash Flow | R$ 5.76 M |
| Increase (Reduction) in Cash and Equivalents | R$ 1.26 M |
| Updated 11/07/2024 | |
Experimental - HBRE3
| CAPEX 3 months | - R$ 6.20 M |
| Free Cash Flow 3 months | - R$ 24.29 M |
| CAPEX 12 months | - R$ 32.73 M |
| Free Cash Flow 12 months | - R$ 368.97 M |
| Updated 11/07/2024 | |